Literature DB >> 10430418

Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia.

K Nänto-Salonen1, M Komu, N Lundbom, K Heinänen, A Alanen, I Sipilä, O Simell.   

Abstract

OBJECTIVE: To analyze in vivo brain creatine (Cr) content in gyrate atrophy of the choroid and retina with hyperornithinemia (GA).
BACKGROUND: GA is caused by inherited deficiency of ornithine-delta-aminotransferase activity. Patients lose their vision by middle age and develop selective atrophy of type II skeletal muscle fibers. As demonstrated by MRS, the patients' skeletal muscles have diminished stores of high-energy Cr phosphate. Minor structural and electrophysiologic abnormalities in the brain of these patients also imply that the CNS may be affected.
METHODS: The authors acquired proton MR spectra of the basal ganglia of 22 healthy control subjects and 20 GA patients. Nine patients received supplementary Cr or its precursors, and one child was on an arginine-restricted diet to normalize plasma ornithine concentration. The ratios of N-acetylaspartate (NAA) to Cr, NAA to choline (Cho), and Cho to Cr, and the ratios of NAA, Cho, and Cr to tissue water were calculated.
RESULTS: NAA/Cr (Cho/Cr) in the untreated and treated patients and control subjects were (mean +/- SD) 3.3+/-0.4, 2.0+/-0.4, and 1.5+/-0.7 (1.9+/-0.3, 1.3+/-0.4, and 0.9+/-0.2), indicating that Cr content in untreated GA patients was proportionally and markedly diminished, and partially corrected by therapy (p < 0.0001). NAA/Cho was similar in all three groups. Cr/water in the untreated patients was only 46%, and increased to 75% of the control ratios in the treated patients (p < 0.0001).
CONCLUSIONS: Hyperornithinemia-associated Cr deficiency in GA also affects the CNS, further supporting the possibility that Cr deficiency also has a pathogenetic role in the retina. The deficiency was partially corrected by Cr supplementation and an arginine-restricted diet.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430418     DOI: 10.1212/wnl.53.2.303

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Oral lysine feeding in gyrate atrophy with hyperornithinaemia--a pilot study.

Authors:  K Peltola; O J Heinonen; K Näntö-Salonen; K Pulkki; O Simell
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

2.  Creatine metabolism in urea cycle defects.

Authors:  Sara Boenzi; Anna Pastore; Diego Martinelli; Bianca Maria Goffredo; Arianna Boiani; Cristiano Rizzo; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2012-05-30       Impact factor: 4.982

3.  Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia.

Authors:  M Valtonen; K Näntö-Salonen; S Jääskeläinen; K Heinänen; A Alanen; O J Heinonen; N Lundbom; M Erkintalo; O Simell
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

4.  Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine.

Authors:  Diego Martinelli; Johannes Häberle; Vicente Rubio; Cecilia Giunta; Ingrid Hausser; Rosalba Carrozzo; Nadine Gougeard; Clara Marco-Marín; Bianca M Goffredo; Maria Chiara Meschini; Elsa Bevivino; Sara Boenzi; Giovanna Stefania Colafati; Francesco Brancati; Matthias R Baumgartner; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2011-12-15       Impact factor: 4.982

Review 5.  International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.

Authors:  Richard B Kreider; Douglas S Kalman; Jose Antonio; Tim N Ziegenfuss; Robert Wildman; Rick Collins; Darren G Candow; Susan M Kleiner; Anthony L Almada; Hector L Lopez
Journal:  J Int Soc Sports Nutr       Date:  2017-06-13       Impact factor: 5.150

Review 6.  Ornithine Aminotransferase, an Important Glutamate-Metabolizing Enzyme at the Crossroads of Multiple Metabolic Pathways.

Authors:  Antonin Ginguay; Luc Cynober; Emmanuel Curis; Ioannis Nicolis
Journal:  Biology (Basel)       Date:  2017-03-07

7.  Urine creatine metabolite panel as a screening test in neurodevelopmental disorders.

Authors:  Shalini Bahl; Dawn Cordeiro; Lauren MacNeil; Andreas Schulze; Saadet Mercimek-Andrews
Journal:  Orphanet J Rare Dis       Date:  2020-12-02       Impact factor: 4.123

Review 8.  Creatine Supplementation in Children and Adolescents.

Authors:  Andrew R Jagim; Chad M Kerksick
Journal:  Nutrients       Date:  2021-02-18       Impact factor: 5.717

9.  Creatine in Health and Disease.

Authors:  Richard B Kreider; Jeffery R Stout
Journal:  Nutrients       Date:  2021-01-29       Impact factor: 5.717

Review 10.  Low Tissue Creatine: A Therapeutic Target in Clinical Nutrition.

Authors:  Sergej M Ostojic
Journal:  Nutrients       Date:  2022-03-15       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.